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Abstract It is well known that nucleic acids play an
essential role in living organisms because they store and
transmit genetic information and use that information to
direct the synthesis of proteins. However, less is known
about the ability of nucleic acids to bind specific ligands
and the application of oligonucleotides as molecular probes
or biosensors. Oligonucleotide probes are single-stranded
nucleic acid fragments that can be tailored to have high
specificity and affinity for different targets including
nucleic acids, proteins, small molecules, and ions. One
can divide oligonucleotide-based probes into two main
categories: hybridization probes that are based on the
formation of complementary base-pairs, and aptamer
probes that exploit selective recognition of nonnucleic acid
analytes and may be compared with immunosensors.
Design and construction of hybridization and aptamer probes
are similar. Typically, oligonucleotide (DNA, RNA) with
predefined base sequence and length is modified by covalent
attachment of reporter groups (one or more fluorophores in
fluorescence-based probes). The fluorescent labels act as
transducers that transform biorecognition (hybridization,
ligand binding) into a fluorescence signal. Fluorescent labels
have several advantages, for example high sensitivity and
multiple transduction approaches (fluorescence quenching or
enhancement, fluorescence anisotropy, fluorescence lifetime,
fluorescence resonance energy transfer (FRET), and excimer-
monomer light switching). These multiple signaling options
combined with the design flexibility of the recognition
element (DNA, RNA, PNA, LNA) and various labeling
strategies contribute to development of numerous selective
and sensitive bioassays. This review covers fundamentals of
the design and engineering of oligonucleotide probes,
describes typical construction approaches, and discusses
examples of probes used both in hybridization studies and in
aptamer-based assays.
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Introduction
Fluorescent biosensors enable highly sensitive and selective
detection of many target bioanalytes [1]. With the recent
advent of DNA probe technology, a variety of fluorescent
biosensors that exploit nucleic acids as bioreceptors have
been engineered. The development of sensitive and selec-
tive sensors based on nucleic acid fragments has become a
very active research field in recent years, because of their
numerous applications including detection and visualization
of DNA and RNA in genomic analyses, monitoring
amplification progress in quantitative PCR (QPCR) assays,
and detection of nonnucleic acid analytes (proteins, small
molecules, metal ions) with aptamer-based sensors [2, 3].
In general, these probes are synthetic DNA or RNA
molecules (with a sequence designed for a specific target
molecule) containing a reporter group that can be monitored
using fluorescence spectroscopy. The chemistry of nucleic
acids is well-known, and their assembly into probe oligonu-
cleotides can be achieved easily, by use of commercially
available synthesizers. A simple probe of this kind labels its
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tions (hybridization, molecular recognition). Alteration of the
fluorescence characteristics of reporter group(s) is exploited
as an analytical signal.
Theobjectiveofthisreviewistointroduceoligonucleotide-
based fluorescent probes as versatile biorecognition tools to
detect or monitor various biological important targets.
Subsequent sections provide an overview of the design
approaches, applications, and characterization of fluorescent
oligonucleotide sensors.
Principles of biosensing
Oligonucleotide-based fluorescent probes can be regarded
as typical examples of biosensor with the general layout
shown in Fig. 1, consisting of a biologically relevant
molecular recognition element integrated to a signal-
transduction element.
Nucleic acid fragments are used as recognition element
but, depending on the recognition mechanism (target–probe
interactions), one can distinguish two categories of oligo-
nucleotide biosensors. One group of probes is known as
hybridization probes and the recognition interactions
depend on complementary matching between target and
probe molecules. Hybridization probes are widely used in
many fields that require detection or monitoring of nucleic
acids including gene microarrays, DNA chips, detection of
gene translocation, monitoring intracellular mRNA and
amplification progress in real-time PCR [4–12]. Sensors
belonging to the second group are known as aptamer
probes; these can bind nonnucleic acid analytes acting as
three-dimensional bioreceptors. Applications of aptamer
sensors include detection and monitoring of proteins,
small bioactive molecules, or even metal cations [3, 13,
14]. Transduction of the analyte–bioreceptor binding into
an analytical signal is achieved by attachment of one or
more fluorescent groups to the oligonucleotide chain.
Successful design of the fluorescent probe is apparent
from advantageous changes in the fluorescence properties
of labels (fluorescence quantum yield, lifetime, or other
fluorescence characteristic) resulting from binding of the
target analyte.
Recognition element
The natural nucleic acids (DNA, RNA) are generally used
as recognition elements but some of their synthetic
analogues, for example the peptide nucleic acids (PNA)
and the locked nucleic acids (LNA) have recently been
proposed [15–20]. PNAs are DNA mimics in which a
peptide-like repeat of the (2-aminoethyl)glycine unit replaces
the sugar–phosphate backbone [15, 16]. PNAs recognize and
bind to their complementary nucleic acid sequences with
higher thermal stability and specificity than the corresponding
oligodeoxyribonucleotides; this was exploited to develop
Light-up probes for microchip applications and detection of
PCR products [17]. Locked nucleic acids, defined as
oligonucleotides containing at least one LNA monomer, are
a new class of bicyclic high-affinity DNA analogues [18].
The LNA monomer contains a natural phosphodiester
linkage, but its sugar is conformationally locked by an O2′
to C4′ methylene linkage. LNAs are capable of recognizing
complementary DNA and RNA with increased mismatch
discrimination compared with natural nucleic acids that
enable full control of the melting point of the hybridization
reaction [18]. With these unique properties, LNAs have
found widespread applications in biotechnology (drugs,
primers) and in bioanalysis as effective detection probes.
They are particularly well suited to SNP (single nucleotide
polymorphism) genotyping microarrays, QPCR (quantitative
polymerase chain reaction), and FISH (fluorescence in-situ
hybridization) assays [19, 20].
Although the nucleic acid sequences for hybridization
probes are related to the genomic DNA or mRNA, the
aptamer sequences may vary freely and depend on the
target analytes. Aptamers that are able to bind desired target
molecules selectively are generated from a random library
of 10
15–10
18 candidates by in-vitro selection known as the
SELEX (systematic evolution of ligands by exponential
enrichment) technique [21, 22].
Fluorescence transduction
With progress in automated DNA synthesis and phosphor-
oamidite chemistry, it has become possible to attach
fluorophores covalently to an oligonucleotide of interest.
Different fluorescent dyes have been used to engineer
oligonucleotide probes, for example fluorescein, TAMRA,
Cy dyes, Texas red, HEX, JOE, Oregon green, rhodamine
6 G, coumarin, pyrene, and others. Additionally, in fluores-
cence quenching approaches, quencher molecules have also
been covalently attached to the fluorescent oligonucleotides.
Dimethylaminophenylazobenzoic acid (DABCYL) has been
widely used as a universal quencher for many fluorophores
[23]. The fluorophores and quenchers may be easily chosen
for the desired probe application. However, for successful Fig. 1 Schematic layout of a fluorescent biosensor
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considerations must be taken into account, for example the
photostability of the fluorophore, the pH-dependence of
quantum yield, the nature and length of a linker, and the
position of the fluorophore attachment (end vs. internal
modification) [24–26]. Dye–nucleotide interactions were
reported to be responsible for the sensitivity of fluorescent
conjugates to environmental conditions and it was proposed
thatphotoinducedelectrontransferbetweendyeandguanosine
is crucially important in the process [25–29].
The fluorophores used for oligonucleotide labeling can
be divided into two classes:
1. dyes that change their fluorescence properties on
binding nucleic acids, used mainly in single-labeled
probes, and
2. fluorophores with intrinsically strong fluorescence, for
example fluorescein and rhodamine derivatives, which
through structural design are brought into contact with
each other or with a quencher molecule.
The mechanism of signal transduction for single-labeled
probes may rely on several different processes including the
above mentioned electron transfer quenching or dequenching
with the participation of nucleobases, fluorescence enhance-
ment as result of energy transfer from nucleobases to the
acceptor [30], or steric restrictions imposed on the fluo-
rophore that operate in Light-up probes [17]. Fluorescence
intensity-based transduction, however, suffers from the
sensitivity of the analytical signal to matrix effects and
assay conditions. To overcome these problems, more
advanced fluorescence techniques have been used, for
example fluorescence polarization or anisotropy [31, 32]
and fluorescence lifetime [33, 34].
Transduction processes responsible for the performance
of probes containing two dyes may rely on fluorescence
quenching (static or dynamic mechanisms), fluorescence
resonance energy transfer (FRET), and monomer–excimer
emission switching with pyrene fluorophores. Energy
transfer, quenching, and excimer formation processes are
distance-dependent, thus structural rearrangement of the
probe upon binding to the target that changes the distance
between the attached fluorophores should result in an
alteration of the fluorescence characteristics of the system.
Fluorescence resonance energy transfer
Fluorescence resonance energy transfer (FRET) is a
spectroscopic method that provides distance information
about macromolecules in solution and is particularly suited
to analysis of structural changes in proteins and nucleic
acids [35]. In a typical FRET experiment, a biopolymer is
labeled with two different fluorophores, a donor and an
acceptor, covalently attached at different locations. Interac-
tions between the electronic excited states of these dye
molecules lead to the transfer of excitation energy in a
nonradiative process from the donor molecule to the acceptor
molecule. The occurrence of FRET depends upon such
conditions as the distance between the donor and acceptor
fluorophores (typically 10–80 Å), the spectral overlap
between the donor emission and acceptor absorption spectra,
and the orientation of transition moments of both fluoro-
phores. [35, 36]. The efficiency (E) of FRET can be
measured by looking at the decrease in the fluorescence (or
lifetime) of the donor or at the increase in the fluorescence of
the acceptor. Förster showed that FRET efficiency depended
on the inverse sixth power of the distance (R) between the
two fluorophores (Eq. 1) and this is the basis of the use of
the technique to provide structural information [36].
E ¼ 1 þ R6=R6
0
  1
ð1Þ
where R0 is the characteristic Förster radius for a given
donor–acceptor pair, which is given by:
R6
0 ¼ 8:8   10 28ΦDk2n 4J n ðÞ ð 2Þ
where ΦD is the fluorescent quantum yield of the donor in
the absence of the acceptor, κ
2 is a term that depends on the
relative orientation of the donor and acceptor transition
moments, n is the refractive index of the medium, and J(ν)i s
the spectral overlap between the donor emission and
acceptor absorption spectra. From Eq. 1 it is clear that for
R = R0, the efficiency of FRET is 50%.
Detection and the quantification with FRET can be
accomplished in a number of ways. If the acceptor
molecule is fluorescent, the ratio of the quenched fluores-
cence of the donor to the sensitized fluorescence of the
acceptor can be used to detect FRET. This method has the
advantage that the signal ratio is independent of the absolute
concentration of donor and acceptor, in contrast with the
approach with a quencher as the acceptor, where knowledge
of absolute concentrations is required. FRET techniques have
been used in a number of studies focused on oligonucleotide
probes. Two design strategies are commonly used, the
approach in which both energy transfer partners are attached
to the same oligonucleotide at the 3′ and 5′ termini (e.g.,
molecular beacons (MB), hydrolysis probes) and the two-
oligonucleotide strategy (binary probes, BP), used mainly in
hybridization assays, in which two short oligonucleotides are
single-labeled with the donor and acceptor fluorophores. The
BP and MB probes will be described in detail in subsequent
sections.
Excimer–monomer switching
It is well known that an excited pyrene molecule can form
an excited-state weak association complex with another
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excimer has a broad red-shifted emission band near
480 nm, compared with the structured emission of the
pyrene monomer at 400 nm. A properly designed oligonu-
cleotide probe will switch between excimer and monomer
emissions depending on the presence of analyte target (free
and bound states of the probe). Labeling of the oligonucle-
otide probe with pyrene can be carried out in a variety of
ways, including simple end-labeling via a linker [12, 38–
40], a 2′ sugar modification [41], attachment of pyrene to
the nucleobase [42, 43], incorporation of bis-pyrene label
[44–46], and by arraying multiple pyrene residues along the
DNA backbone [47].
Another important photophysical property of pyrene is
its relatively long fluorescence lifetime approaching 100 ns
in aqueous solution [37]. Moreover, the excimer emission is
also long-lived [48]; this can be exploited in a time-
resolved emission spectra (TRES) approach. Short-lived
autofluorescence background of biological samples can be
eliminated using TRES that greatly improves signal to
background (S/B) ratio [39].
Hybridization probes
Detection of DNA hybridization is widely used in molec-
ular biology, genetics, and medical diagnostics. The most
frequently studied systems are related to the polymerase
chain reaction (PCR), microarray technology, and fluores-
cence in-situ hybridization (FISH). There are many formats
for hybridization assays. All approaches require at least one
analytical oligonucleotide (probe) with complementary
sequence to the oligonucleotide analyte, also referred to as
the oligonucleotide target. Many hybridization formats are
heterogeneous with a probe or an analyte attached to a solid
support. This facilitates the separation of hybridized and
unhybridized oligonucleotides. These assays do not need
the fluorescence characteristics of the label to be altered by
the hybridization between probe and target, because excess
reagent is usually washed out. Unfortunately, the require-
ment that the unhybridized probe has to be removed by
washing, precludes the use of this format for on line
monitoring of hybridization. The solid-state-supported
approach is widely used in DNA chips, microarrays, and
DNA sensor technology and will be not considered in this
review.
The homogeneous, or solution-phase, assays have the
advantage that insoluble supports are absent (elimination of
the problem with nonspecific adsorption) but rely on the
strategy that requires alteration of the fluorescence proper-
ties of the label(s) on hybridization. Several design
strategies have been used to detect hybridization with
homogeneous assays. Some possible approaches are shown
schematically in Fig. 2. The most important strategies are
thebinaryprobe(Fig.2a, b) and molecular beacon (Fig. 2c, d)
approaches.
Binary probes
An early homogeneous assay was reported by Heller and
Morrison [49]. They used two probes complementary to the
target oligonucleotide. The probes were single-labeled with
fluorophores at the 3′ and 5′ ends. After hybridization to
complementary oligonucleotide at the adjacent locations,
the labels were close enough to enable strong fluorescence
quenching (Fig. 2a). In another approach a competitive
hybridization between a labeled DNA duplex probe and
target DNA was exploited [50]. Two single-labeled probes
on 3′ and 5′ termini were also used, but the probes were
complementary to one another. Efficient static quenching of
the hybridized probe duplex was observed when one strand
was labeled with a fluorescence quencher. Competitive
hybridization with the target DNA produced a fluorescence
signal as a result of a dequenching process (quencher
labeled strand dissociation).
Recent applications of binary probes rely mainly on the
FRET approach [2, 5, 6, 51]. Typically, one oligonucleotide
is labeled with a donor fluorophore and the other is labeled
with an acceptor molecule (dyes are selected to form a
FRET pair). In the absence of target DNA, the donor and
acceptor strands are randomly distributed in solution, and,
because their concentration is very low, the intermolecular
Fig. 2 Schematic representation of nucleic acid hybridization probes:
quenching-type binary probe (a), FRET-type binary probe (b),
quenching-type molecular beacon (c), and FRET-type molecular
beacon (d)
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hybrid is formed in which the acceptor and donor strands
hybridize in the adjacent sites on the target (Fig. 2b). Close
proximity of the donor and acceptor fluorophores results in
generation of a FRET signal. In an ideal BP assay, selective
excitation of the donor fluorophore enables observation of
only donor fluorescence in the absence of target and strongly
sensitized emission of the acceptor with quenched donor
fluorescence when the target DNA is present. In practice, the
acceptor emission is also present in the absence of target,
because of direct excitation, which together with the limited
FRET efficiency causes lowering of the signal/background
ratio [5, 52]. The challenge of improving the S/B ratio has
been addressed by constructing probes that rely on the three-
fluorophore approach reported by Marti et al. [53]. Their
probe system contains the FAM–TAMRA–Cy5 FRET triad.
One probe is labeled with FAM and TAMRA separated from
one another by four nucleotides; the second probe is labeled
with Cy5. In the absence of target, excitation of FAM gives
only TAMRA emission (efficient FRET); on hybridization of
probes to the target, TAMRA and Cy5 are brought into
proximity and FRET operates between TAMRA and Cy5,
which results in the appearance of Cy5 fluorescence and a
decrease in TAMRA emission. This relayed FRET results in
good spectral separation (Stokes shift) between the primary
donor (FAM) and the final acceptor (Cy5). Another way to
improve the S/B ratio of binary probes is by application of
pyrene labels that are able to produce excimer emission [12,
54, 55]. When the two probes are free in solution, the pyrene
groups are separated from each other and pyrene monomer
fluorescence is observed without a contribution from excimer
emission. When the probes are hybridized to the target, the
pyrenegroupsare closetoone another,favoringthe formation
of the excimer. S/B for the probe in buffer is excellent, but in
the presence of the protein extract the “autofluorescence” of
the biological background results in disturbance, leading to a
poor S/B ratio. A time-resolved emission spectra (TRES)
approach, used instead of steady-state measurements, elimi-
nated the background autofluorescence as the result of longer
lifetime of pyrene emission [12].
Among other attempts to improve the sensitivity and
selectivity of hybridization monitoring, one can mention the
use of the pyrene–perylene FRET pair coupled to a 2′-
amino-LNA oligonucleotide probe with clear distance-
dependent FRET efficiency [56], or application of micellar
medium (cetylpyridinium bromide) that enhanced FRET
between FAM and TAMRA-labeled probes in a sandwich-
type assay [57].
An advantage of binary probes is that they do not yield
false positive or nonspecific signals similar to those
observed for molecular beacons. There are, however, some
disadvantages of binary probes which have stimulated
intense research yielding novel and creative approaches.
First, the entropy of a binary probe system decreases more
when bound to the target (three independent species
becoming one hybrid), which reduces the equilibrium
stability of the hybrid [58]. Furthermore, the hybridization
kinetics of binary probes is slower than that of MB because
BP hybridization depends on the binding of two different
components to the target. To challenge these limitations,
two separate binary probes have been covalently linked
with a poly(ethylene glycol) chain; this significantly
improved the hybridization kinetics and the thermodynamic
stability of the hybrid [59].
Molecular beacons
The most common DNA and RNA hybridization probes are
molecular beacons (MB). The first MB, described by Tyagi
et al. [4], was based on fluorescence quenching and
complementary pairing principles. Figure 2c shows the
general structure of the MB and its working principle. The
classic MB is a fluorescently-labeled oligonucleotide
comprising three parts:
1. a loop of 15–30 nucleotides, which can recognize a
target molecule;
2. a stem of 5–8 bases, which dissociates during the
hybridization of the MB with a target molecule; and
3. a fluorescent group connected to the 5′ end and a
quenching group linked to the 3′ end of the MB.
Unhybridized MB has the structure of a hairpin with
fluorophore and quencher probes placed close to each other.
As a result, the fluorescence quenching or FRET occur
between the fluorophore and the quencher. However, in the
presence of the target, the probe region of the MB
hybridizes to it, promoting the opening of the hairpin
conformation and separating the fluorophore and the
quencher from each other. The fluorophore fluorescence is
not quenched after hybridization because of the separation
of the fluorophore and quencher. This results in the
appearance of fluorescence emission from the fluorophore
only after the probe has selectively hybridized to the target.
The substitution of quencher molecule with another
fluorophore enables construction of FRET-based molecular
beacons (Fig. 2d). FRET MBs have several advantages, for
example the possibility of ratiometric analysis to improve
the S/B ratio, and use of two-channel detection that enables
monitoring of free and bound probe in cells [60]. Briefly, in
the hairpin conformation, the two fluorophores (the donor
and acceptor molecules) are close to each other; this leads
to FRET between them, whereas on hybridization with the
target, the donor and acceptor fluorophores become
separated in space leading to strong, unquenched emission
of the donor (FRET is not observed).
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structural changes of MBs in the presence of complemen-
tary nucleic acids. Because of their simplicity and high
specificity, MBs have been used to detect SNPs and gene
mutations, to quantify the concentration of a target
molecule during real-time or quantitative PCR (Q-PCR),
or to carry out intracellular imaging of nucleic acids [5–12,
61–74]. These applications involve both quencher-based
and FRET MBs. A mixed quenching/FRET approach has
been also proposed to improve the signal/background ratio
for detection of mRNA in living cells [61, 62]. Using a pair
of classical molecular beacons, one with a donor and the
other with an acceptor fluorophore, that hybridize to
adjacent regions on the same mRNA target, FRET-based
monitoring of mRNA was achieved with an advantageous
S/B ratio when compared with the single MB approach.
Detection of the FRET signal significantly reduced false
positives, leading to sensitive imaging of mRNAs in live
cells [61].
Despite many obvious advantages and applications there
are some disadvantages and limitations that are challenged
by intense research. Most of the problems arise either from
the complexity of living environments or the intrinsic
properties of MBs. For instance, MBs can be easily
degraded by intracellular enzymes or non-specifically
opened by single-strand-binding proteins (SSBs) causing
false-positive or false-negative signals. Application of non-
standard nucleic acids (2′OMe-modified RNA, PNA, and
LNA) was helpful in solving this problem [63–65]. Another
advantage of replacing the natural nucleic acids with their
analogs includes higher affinity, increased specificity, faster
hybridization kinetics, and fluorescence background sup-
pression, because of reduction of dynamic opening of stem
structure [66]. For improvement of the MB signaling
properties several different approaches have been reported.
One strategy is to apply brighter fluorophores, for example,
quantum dots or organic polymers [67, 68]. Another
approach used to increase S/B ratio relies on application
of more effective metal quenchers (e.g., Au nanoparticles)
or multiple quenchers [69, 70]. For example, use of MB
with fluorescein and multiple DABCYL quencher resulted
in 14, 81, and 320-fold signal enhancement as the number
of quenchers was increased from one to three, respectively
[70]. For FRET-based MBs, it is, in practice, difficult to
eliminate a direct excitation of the acceptor at the donor
excitation wavelength or to avoid an overlap between
emission spectra of the donor and the acceptor. Tailoring
new FRET fluorophores [75–77] and modifications of the
“classical” architecture of MBs [78–81] have enabled
enhancement of detection capabilities with better S/B ratio
and lower LOD values. Comprehensive papers have been
published recently that discuss and compare FRET con-
ditions for numerous donor–acceptor pairs of organic
fluorophores [75] and quantum dots [66, 76]. Quantum
dots (QDs) are especially well suited to FRET applications.
The broad excitation spectra and large absorption cross
section of QDs, combined with the narrow excitation
spectra of acceptor dyes, enable one to choose the most
appropriate excitation wavelength to reduce unwanted
direct excitation of the acceptor and thus increase FRET
efficiency. Moreover, because the emission spectrum of the
QD donor is narrow, symmetric, and has no red tail, the
overlap with the fluorescence spectrum of the acceptor is
minimized. FRET efficiency can also be enhanced because
multiple acceptors can interact at the surface of a single QD
[76]. One such example made use of two probes, a reporter
probe labeled with an organic fluorophore and a capture
probe labeled with biotin. In the presence of the target
DNA, these two probes hybridized as a sandwich hybrid
that could be captured by streptavidin-coated QDs [82].
This nanoassembly enabled FRET to occur from the QD to
the fluorophores in close proximity, and the system had
major advantages such as amplified or multiple FRET
response (colocalization of two fluorescent signals) or
reduced S/B ratio (unhybridized probes do not participate
in FRET background). Performance of the QD-labeled MB
can be further improved by the presence of graphene oxide
(GO) [83, 84]. The ability of GO to differentiate hairpin and
dsDNA structures [85], is a new approach to discriminating
between intact (free) MB and open (hybridized) MB forms.
The strong interaction between free QD-labeled MB and
GO led to the fluorescence quenching of QDs. On
recognition of the target (double-stranded hybrid forma-
tion), the interaction between target-bound MB and GO
became weaker, and the distance between the QDs and GO
increased, which significantly hindered the FRET and, thus,
increased the fluorescence of QDs [84]. Another promising
improvement of MB performance relies on the application
of the luminescent lanthanide chelates as MB labels.
Recently, Krasnoperov et al. reported ultrasensitive detec-
tion of nucleic acids by MB labeled with Eu(III) chelates of
quinolone derivatives [77]. Time-resolved acquisition of the
luminescent signal that occurs on hybridization of the probe
to the target enabled elimination of short-lived background
fluorescence, significantly enhancing the sensitivity of
detection, which was less than 1 pmol L
−1 [77].
Another approach to improving MB sensitivity and S/B
ratio was based on modification of MB platform by
incorporation of the third fluorophore into the hairpin
structure [78–81]. The MB system reported by Li et al. [81]
consisted of three distinct fluorophores, FAM, TAMRA,
and Cy5. FAM as the primary donor was attached to one
arm of MB, whereas the primary energy acceptor/secondary
donor (TAMRA) and the secondary acceptor (Cy5) were
located at the other terminus of the MB. In the absence of
target DNA or RNA, the MB exists in the stem-closed
3162 B. Juskowiakform. Excitation of FAM initiates an energy transfer
cascade to TAMRA and further to Cy5 generating unique
fluorescence signatures defined as the ratio of the emission
from each of the three fluorophores. In the presence of the
complementary target DNA, the MB opens and hybridizes
with the target, separating FAM and the TAMRA–Cy5 pair
by a large distance, so that energy transfer from FAM to
TAMRA is blocked.
Beside disadvantages related to imperfect spectral
characteristics of MB probes, there are other difficulties
related to proper design of a stem sequence of MB. Its
stability must be finely tuned to ensure close proximity of
the dyes in the native form and, at the same time, enable
efficient hybridization with the target. Additionally, MB
should not take part in unintended target hybridization,
which might affect selectivity, or interfere with formation of
the hairpin structure, for example by binding to the stem
sequence, which may also lead to an increase in back-
ground or loss of signal intensity. To avoid incomplete
FRET or quenching in a hairpin form, Haner et al. reported
MB design in which signal control is accomplished by
formation of a donor–acceptor (D–A) complex [86]. The
stem contains incorporated pairs of pyrene or perylenedii-
mide moieties that can interact by interstrand stacking. In
the native structure this leads to efficient quenching of
pyrene fluorescence, whereas the hybridized form is
characterized by an excimer signal produced from two
adjacent moieties. Additionally, the formation of a stable
D–A complex helps to minimize the number of natural
bases in the stem, thus reducing the chances of unwanted
base-pairing interactions.
The excimer monomer switching (EMS) approach with
pyrene fluorophore has been widely used in developing MB
probes. The first EMS MB was reported by Fujimoto et al.
[38]. In this approach, two pyrene groups were attached at
both termini of the MB. When the Py-MB is in the hairpin
conformation, the pyrene groups are close to one another
and excimer emission can be observed. In contrast, in the
presence of the target, the pyrene groups are at opposite
sites of the strand and only monomer emission is produced.
An isoemissive point was observed indicating the presence
of only two fluorescent species, the nonhybridized and
hybridized probes. The EMS MB approach enhances the
fluorescence output and enables a time-resolved signaling
option for improved background discrimination. Several
such probes have been synthesized; these differ in the
chemistry used to attach pyrene to the oligonucleotide
strand, the length of the linker chain, and the strand position
where the pyrene group is attached [46, 87–90]. It has also
been shown that the intensity of the excimer emission and
base-pair mismatch discrimination can be enhanced by
labeling one arm of the MB with a bis-pyrene group,
contrary to the classical MB approach with pyrene attached
to both termini of the MB. Strong excimer fluorescence was
observed for MB labeled with bis-pyrene in the stem-loop
form, whereas for the hybrid with a target monomer
fluorescence was the major spectral component [46].
Conlon et al. [88] reported a multiple-labeled MB probe
that signaled hybridization by quenching of pyrene excimer
emission. The 5′ end of the MB was modified with 2–4
pyrene molecules using dendrimer linkers, and the quencher
DABCYL was attached on the 3′ end. A stem-closed
conformation resulted in quenching of the pyrene excimer
fluorescence. In the presence of the target, the beacon
switched to a stem-open conformation, which separated the
pyrene labels from the quencher molecule and restored the
excimer emission signal in proportion to the target concen-
tration. Steady-state fluorescence or time-resolved assays
enabled a subnanomolar detection of the target in buffer or
in cell-growth medium, respectively. The excimer emission
intensity could be scaled by increasing the number of pyrene
monomers conjugated to the 5′ terminal [88].
An ethynylpyrene group was used by Kim et al. to modify
the nucleobases adenosine (A
P) and uridine (U
P)[ 42, 89].
These modified nucleotides were incorporated into the
middle positions of hairpin stem to form MB stabilized by
stacking interactions between modified opposite bases [89].
The close location of the nucleobase (rigid ethynyl bridge)
seriously affected pyrene spectral behavior, with U
P being
nonfluorescent and A
P with much higher fluorescence
quantum yield. Moreover, U
P quenched fluorescence of A
P
when they formed a stacking complex (U
PA
P)w i t h i nt h eM B
stem, but excimer-like red-shifted emission was observed for
the system with the A
PA
P pair. Hairpins with the A
PA
P and
A
PU
P pairs were proposed as efficient MB that change the
fluorescence properties on forming their perfectly matched
duplexes [89]. Another approach with pyrene moieties
inserted into the stem of MB was described by Matsumoto
et al. [90] who incorporated into the MB stem one or two
guanosines conjugated with pyrene through C8 alkylamino
linkers. These flexible connectors enabled the pyrene
moieties to intercalate into the stem of the MB, which
resulted in efficient quenching of the pyrene fluorescence in
a stem-closed configuration (probably because of an
electron-transfer mechanism [27]). This quencher-free MB
probe emitted monomer or excimer emission after hybrid-
ization with the target, depending on the number of pyrene
labels attached.
Other probes
Molecular beacons and binary probes are excellent tools for
sequence-specific detection of nucleic acids. However, real-
time monitoring of amplification reactions, as in quantita-
tive polymerase chain reaction (QPCR) systems, sometimes
require more sophisticated probe designs [11, 91]. The
Nucleic acid-based fluorescent probes and their analytical 3163QPCR technique enables detection and quantification of
minute numbers of copies of target nucleic acid sequences
isolated from biological material. The basis of the PCR
technique is the ability of DNA polymerase to extend an
oligodeoxyribonucleotide primer that is specifically hybrid-
ized to a single-stranded DNA template. PCR consists of
three thermally different steps that constitute one amplifi-
cation cycle. Multiple rounds of thermal cycling result in
exponential accumulation of PCR products. For example, in
30 thermal cycles 108-fold amplification of the target
sequence can be achieved. There is a quantitative relation-
ship between the number of target nucleic acid strands
initially present in a sample and the number of product
strands synthesized at any given thermal cycle. Therefore,
real-time monitoring of amplification progress in closed
tubes is required; this can be achieved by use of
fluorescence-based hybridization probes or primers. Beside
binary probes and molecular beacons widely used in QPCR
analysis, a hydrolysis probe has been developed [92, 93]
that is based on the inherent 5′ → 3′ exonuclease activity of
the Taq DNA polymerase [94]. This hydrolysis probe
(known also as a TaqMan probe) is a dual-labeled
fluorogenic short oligonucleotide. One end is labeled with
a donor, and an acceptor fluorophore is attached on the
other end of the probe so that they interact with each other
by FRET, because the oligonucleotide is short enough [93]
(Fig. 3a). Probes that are free in solution transfer energy
from the donor fluorophore to the acceptor, resulting in a
low donor fluorescence signal (and/or FRET emission of
the acceptor). The probe is designed to hybridize to the target
strand at the same time as the PCR primer. When Taq DNA
polymerase extends the primer, it encounters the probe, and,
because of its 5′-nuclease activity, it cleaves the probe.
Cleavage of the probe results in separation of the donor and
the acceptor from each other, leading to an increase in the
intensity of the fluorescence signal from the donor fluoro-
phore. With each cycle of amplification, additional fluoro-
phores are liberated from their probes and the increasing
fluorescence intensity is monitored during the extension step
of each PCR cycle. Another hydrolysis probe, a minor
groove-binding (MGB) probe, has been reported [95]. MGBs
are short oligonucleotides characterized by the conjugation
of minor groove binders, for example dihydrocyclopyrro-
loindole, at one end. This chemical modification increases
the stability of the hybridized probe and facilitates highly
specific binding to the targeted sequence at the minor groove
of the DNA helix [95].
Another class of QPCR hybridization probes contains
single-labeled oligonucleotides, fluorescence of which is
quenched by the oligonucleotide component of the probe
by base–dye stacking and electron-transfer. When these
probes hybridize to target sequences, there is an increase in
probe fluorescence emission without a significant change in
probe structure. The HyBeacon and Light-up probes are
examples of such design. HyBeacons are single-stranded
fluorescent oligonucleotides that lack a secondary structure,
but the fluorophore is quenched by internal nucleotides
[96]. When the probe binds to a nucleic acid, its
conformation changes and, as a result, the fluorescence
intensity of the fluorophore increases. Light-up probes
consists of a thiazole orange derivative linked to a PNA
oligomer [97]. On hybridization with a target a duplex
structure is formed in which the thiazole orange moiety
intercalates and, similarly to HyBeacons, the probe becomes
brightly fluorescent. Because of their PNA backbone, Light-
up probes are highly specific: a single base mismatch in the
target sequence is sufficient to prevent probe binding, as
indicated by the lack of fluorescence increase [98].
It is also possible to use QPCR detection systems based
on modified primers that are able to generate fluorescence
signals on target amplification. Examples of such detection
systems include Scorpion primers and Amplifluor primers
[99–101]. The Scorpions method developed by Whitcombe
et al. [99] combines, within a single molecule, both a PCR
primer and a sequence-specific probe (labeled with donor
and acceptor FRET labels). These two sequence moieties
are separated by a non-PCR amplifiable linker (Fig. 3b). In
the absence of target, the donor fluorophore and the
quencher (acceptor) are in close proximity, resulting in
quenching of the fluorophore emission. When the probe
sequence hybridizes to its target sequence, PCR occurs with
the primer moiety and the probe loops forward and binds to
the PCR product strand upstream of the primer, thus
restoring fluorescence. This is a unimolecular reaction
which occurs extremely quickly and efficiently, and is
accompanied by the dissociation of a fluorophore–quencher
pair. Nazarenko et al. developed similar labeled hairpin
primers, called Amplifluor probes [100, 101], that are
directly incorporated into amplification products (Fig. 3c).
The hairpin structure contains a fluorophore and quencher
moiety in the hairpin stem. Hairpin primers that are not
incorporated into an amplification product do not generate a
fluorescence signal, because the reporter and quencher stay
in close proximity. During amplification, hairpin primers
are incorporated into the double-stranded amplification
products and generate a fluorescence signal because they
are linearized by further amplification. Further simplifica-
tion of this approach was achieved with single-labeled
hairpin primers [102]. Similar to HyBeacons and Light-up
probes, these fluorogenic primers contain a single fluoro-
phore that is intrinsically quenched by nucleobases (mainly
guanosine) in a hairpin form. They increase fluorescence
intensity when incorporated into the double-stranded PCR
products. All these systems are less expensive than probe-
based detection formats and may provide an attractive
alternative, especially if multiple targets have to be detected
3164 B. Juskowiaksimultaneously by multiplex reactions [102, 103]. A
disadvantage of this approach is that hairpin primers can
generate “false” amplicons or primer–dimers, resulting in
false-positive fluorescence signals.
Aptamer affinity probes
The flexibility offered by nucleic acids (stability, ease of
chemical modifications and labeling) have stimulated
innovative applications of these species in bioanalysis. It
was demonstrated recently that, like antibodies, nucleic
acids with defined sequences and structures can recognize
specific nonnucleic acid targets. Such single-stranded
nucleic acid sequences are called aptamers.
Selection of aptamers
Most aptamers are obtained by the SELEX method [21,
22, 104]. In a typical DNA aptamer selection, a large
single-stranded DNA library (up to 10
18 random sequen-
ces) is incubated with a target molecule to enable the
binding reaction to occur. The bound and unbound DNAs
are subsequently separated. For small-molecule targets,
separation is usually achieved by use of affinity columns,
by covalently attaching the target molecule to the column
and washing away the unbound DNA. Other separation
formats include filters, magnetic beads [105], gel and
capillary electrophoresis [106], surface plasmon resonance
[107], and atomic force and fluorescence microscopy [108].
Aptamers can be regarded as nucleic acid analogs of
antibodies. Although both have comparable specificity and
affinity, aptamers are more flexible for the design of novel
bioanalytical sensors. A striking feature of aptamers (RNA
and DNA) is the broad range of targets that can be
recognized. Not considering metal cations [109, 110],
aptamers have been engineered for such a small target as
ethanolamine [111] and for many protein targets with high
molecular weights [112, 113]. A comprehensive list of
aptamer targets has been reported [114], including proteins,
organic molecules, ions, viruses, and even organelles. In
addition, aptamers are easily synthesized and suitable for
chemical modification. Aptamers maintain or restore their
functions when exposed to the harsh environmental
conditions. The most interesting aspect of adapting
aptamers to act as biosensors or molecular probes is their
structural flexibility, which means that binding of a target
usually results in structural alteration or rearrangement of
the aptamer [115, 116]. Even if the target binding has
negligible effect on the structural characteristics of the
aptamer, the system is still suitable for bioanalytical
applications, for example, in competition assays with a
Fig. 3 Schematic representation of TacMan hydrolysis probe (a) and fluorescent primers Scorpions (b) and Amplifluor (c) used for monitoring
QPCR amplification progress
Nucleic acid-based fluorescent probes and their analytical 3165fluorescent derivative of the target [117], or the fluorescent
aptamer may serve as a reporter sensor for detection of
target molecules in chromatographic or electrophoretic
separations [118]. However, in many cases the molecular
motions exerted by recognition of the target, although
small, are sufficient to generate an analytical signal, as in
the anti-adenosine aptamer labeled with fluorescein [119].
On the other hand conformational changes can be signif-
icant, leading to global structure rearrangements, as
observed on G-quadruplex formation [13, 109]. Aptamers
that adopt a tetraplex structural motif are among the most
extensively exploited probes for biosensing purposes.
G-quadruplex structures
G-quadruplexes or G4 DNA have the tetraplex structure and
can be formed by single-stranded fragments of nucleic acids
with guanine-rich sequences [109, 120]. G-quadruplexes
have recently received much attention because G-rich
sequences are often found in genomes and because of their
potential links to mechanisms that relate to cancer, AIDS,
and other diseases [121, 122].
The G-quadruplexes have four-stranded structures (DNA
tetraplexes ) containing one or more nucleic acid strands, in
parallel or antiparallel orientations [123]. Four guanines on a
plane, interacting via Hoogsteen bonding, form a G-quartet
as shown in Fig. 4a. Typically, two, three, or four G-quartets
are stacked within a quadruplex and held together by π–π
nonbonded attractive interactions (Fig. 4b–e). The most
interesting feature of the quadruplex structure is the presence
of a central channel formed by stacking of guanine tetrads
that can accommodate some cations selectively. The ion-
binding site is thought to be a cavity between two G-quartets
that is flanked with eight O-6 atoms from guanines
participating in the precise coordination of the cation [123].
The structural polymorphism and stability of G4 struc-
tures depend on many factors including strand stoichi-
ometry and polarity, glycosidic torsion angle, connecting
loops, and the nature of coordinated metal cation [123,
124]. For example, the sodium quadruplex formed by the
human telomeric DNA sequence, d[AG3(T2AG3)3], has an
antiparallel strand orientation with the basket-type struc-
ture (c in Fig. 4)[ 125], whereas the potassium complex
has a variety of G-quadruplex structures ranging from
antiparallel basket- or chair-type structures (b and c in
Fig. 4) to parallel and hybrid conformations (d and e in
Fig. 4)[ 123, 124, 126]. In contrast, the thrombin-binding
aptamer (5′-d(GGTTGGTGTGGTTGG)-3′) forms only
one G4 structure, a chair-type quadruplex (b in Fig. 4),
irrespective of the metal cation coordinated [127]. Knowl-
edge of the structural details of a particular G-quadruplex
is crucial for the rational design of FRET probes if one
considers different orientations of both termini of an
oligonucleotide. Beside metal cations, several promising
small organic molecules have been devised to selectively
promote the formation and/or stabilization of guanine-
quadruplex structures, ranging from derivatives of anthra-
quinones to porphyrins, acridines, and others planar
compounds [128]. Another interest in G-quadruplexes is
connected with their biological significance. Beside
involvement in the regulation of telomerase activity, G-
quadruplexes have been linked to proteins that either
specifically bind to or promote the folding of quadruplex
structures [113, 129]. Thrombin-binding aptamer (TBA) is
a good example of an oligonucleotide that exploits
quadruplex motif for thrombin-binding [113].
Intramolecular folding of a flexible single-stranded DNA
molecule into a compact G-quadruplex is a structural
transition leading to closer proximity of its 5′ and 3′ ends.
Thus, labeling both ends of a DNA strand with the donor
and acceptor fluorophores enables monitoring of the
quadruplex-formation process by means of the FRET
Fig. 4 Structure of G-tetrad
showing hydrogen bonds
between four guanines and the
interactions with a cation (a) and
schematic representation of
G-quadruplex structures:
an antiparallel “chair-type”
G-quadruplex with all lateral
loops (b), an antiparallel
“basket-type” G-quadruplex
with one diagonal and two
lateral loops (c), a hybrid-type
quadruplex with parallel-
antiparallel loops orientation
(d), and a parallel quadruplex
with all loops positioned
alongside the grooves (e)
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of a FRET system based on tetraplex DNA, showing
intramolecular folding of oligonucleotides with sequences
corresponding to human c-myc protooncogene labeled with
fluorescein (FAM) and tetramethylrhodamine (TAMRA) at
the 5′ and 3′ ends, respectively [130]. The pyrene excimer
monomer-switching approach has been also exploited in the
monitoring of G-quadruplex folding [40]. Examples of
fluorescence-based probes with the G-quadruplex motif are
described in subsequent sections.
Detection of proteins
Aptamers with sequences characteristic of particular
protein-binding regions can be used for protein recognition
[131]. Tan et al. have used the molecular beacon strategy to
study protein–DNA interactions [132]. In the presence of
single-stranded DNA binding protein (SSB), the beacon
was opened and fluorescence enhancement was observed,
similar to that induced by the complementary DNA target.
Anti-thrombin aptamer is an example of an oligonucle-
otide that exploits a quadruplex motif for thrombin-binding
[113]. This 15-mer oligonucleotide, with the sequence 5′-d
(GGTTGGTGTGGTTGG)-3′, forms an intramolecular
quadruplex with two G-tetrads that strongly binds to
thrombin. Different strategies have been proposed for the
design of thrombin-signaling systems [133–137]. Hamaguchi
etal.reportedamolecular-beaconapproachwiththethrombin
sequence extended by addition of five nucleotides to the
5′ end to obtain an MB with a stem-loop structure [133]. A
fluorophore–quencher pair (fluorescein–DABCYL) attached
to the 5′ and 3′ ends, respectively, of the stem was
responsible for signaling thrombin-dependent conformational
changes. In the absence of thrombin, the aptamer formed a
beacon(stem-loop) conformationwiththe fluorescencesignal
quenched. Addition of thrombin shifted the equilibrium
toward the quadruplex (thrombin-binding conformation) that
destroyed the hairpin structure and caused a change in the
distance between the fluorophore and the quencher, resulting
in a dequenching effect (Fig. 5a). The system could detect
less than 10 nmol L
−1 thrombin, with a maximum
fluorescence increase of 2.5-fold.
A simpler approach for a thrombin sensor was presented
by Tan et al. [134]; fluorescent reporter groups were
attached directly to the 5′ and 3′ ends of the 15-mer
thrombin aptamer via one-base spacers (Fig. 5b). Two types
of thrombin probe were tested:
1. a quenching type (labeled with a fluorescein-DABCYL
pair); and
2. aFRETprobe(coumarin–fluoresceinasadonor–acceptor
pair).
For both sensors sensitivity was rather modest, with 60%
quenching of the fluorescence signal observed for the
quenching probe and a twofold increase in the energy-
transfer signal with the same concentration of thrombin as
for the FRET-based aptamer. The FRET-based assay was
adapted to a microarray format and the fluorescence
intensity was recorded with a digital camera. Ratiometric
imaging was found to increase the signal-to-background
ratio, and thus afforded greater sensitivity in thrombin
imaging.
A more general approach for preparing fluorescent
signaling aptamers was presented by Nutiu and Li [135].
Three synthetic oligonucleotides were used to obtain a two-
stem duplex assembly (Fig. 5c). The first strand was
modified with a fluorophore at the 5′ end (F-labeled
strand); the second contained a quencher at the 3′ end (Q-
labeled strand) and the third unmodified strand contained
regions complementary to the F and Q-strand sequences
and a thrombin-binding domain. When the target (throm-
bin) was introduced, the duplex structure transformed into
the thrombin–quadruplex complex with release of Q-
labeled strand and enhancement of the fluorescence signal
(dequenching). The fluorescein–DABCYL system was
used as a fluorophore–quencher pair. The disadvantage of
this approach was a relatively slow response at room
temperature.
Fig. 5 Schematic representation of generation of fluorescence with
different aptamer affinity probes
Nucleic acid-based fluorescent probes and their analytical 3167Aptamer beacons have also been constructed by splitting
aptamers into two fragments. Yamamoto et al. reported
such an aptamer beacon for HIV tat protein [136]. The
aptamer sequence was divided into two parts, with one part
in the hairpin conformation (labeled to form an MB system)
and the other as a separated unlabeled strand (Fig. 5d). In
the presence of the target analyte (Tat protein of HIV); the
two parts self-assembled to bind the analyte and thus
separated the quencher from the fluorophore, resulting in
increased fluorescence. In the presence of 200 nmol L
−1 Tat
protein a ∼14-fold increase in fluorescence intensity was
observed.
Most protein assays are based on recognition of protein
by one aptamer. Heyduk et al. [137] introduced an assay
using two MBs. The assay involved protein-induced
hybridization of two aptamers, recognizing two distinct
epitopes of the thrombin. Thrombin has two known
aptamers that bind to two different sites on thrombin. An
essential condition of this assay was stronger bivalent
binding of both aptamers at the same time compared with
binding of aptamers one at a time. The designed aptamers
were covalently linked to the “signaling” 7-bp oligonucleo-
tides with donor or acceptor fluorophores. In the absence of
thrombin, donor and acceptor aptamers were randomly
distributed in solution and an intramolecular FRET signal
was not observed. On addition of the target protein, the
binding of both aptamers to the same thrombin molecule
brought the donor and acceptor fluorophores close to each
other, resulting in generation of a FRET signal. By using
fluorescein and Cy5 as a FRET pair, they were able to
detect as little as 50 pmol L
−1 thrombin [137].
The pyrene excimer monomer switching (EMS) approach
has been used by Tan and co-workers to design a wavelength-
shifting aptamer probe by labeling a platelet derived growth
factor (PDGF)-binding DNA aptamer with two pyrene
molecules [39]. The aptamer was optimized such that the
two ends were far away in the absence of PDGF but close to
each other in the presence of target (a working principle
similar to that shown in Fig. 5b). On PDGF binding, the
aptamer switched its fluorescence emission from 400 nm
(pyrene monomer, with a fluorescence lifetime of ∼5n s )t o
485 nm (pyrene excimer, with a lifetime of ∼40 ns). The
wavelength-shifting and time-resolved measurement capa-
bilities make the system useful for sensing in complex
sample matrixes, for example cell media, in which strong
background fluorescence often makes intensity-based detec-
tion difficult. A FRETassay for PDGF was developed by the
same group by appending a fluorophore and a quencher to
the termini of the anti-PDGF aptamer [138]. In the absence
of PDGF, the aptamer was largely denatured and its ends
were far apart. Fluorescence quenching was observed when
two termini were brought together as result of the structural
transition of the aptamer imposed by PDGF.
Most research on aptamer probes has been performed
with organic fluorophores in the visible region of the
spectrum. To overcome problems with high background of
the biological matrix, Zhang et al. designed a near-infrared
(NIR) fluorescent aptamer probe that could sense NF-kB
p50 protein-transcription factor [139]. The sensor had
donor–acceptor NIR fluorophores with an emission excita-
tion spectral overlap suitable for the FRET approach.
Detection of aptamer–protein interactions in vivo by NIR
dyes has an advantage over visible fluorescence labels
because of much lower light scattering and absorption in
the tissue. However, the choice of such fluorophores is
limited.
Nanoparticles (NPs) have been also used in the develop-
ment of aptamer sensors for proteins. Zhao and co-workers
used AuNPs as quenchers for designing structure-switching
aptamer sensors for thrombin detection [140]. Under their
experimental conditions, recognition of thrombin by the
hybrid of a TAMRA-labeled DNA strand and anti-thrombin
aptamer was immobilized on gold NPs was possible. In
another approach, Ellington et al. used quantum dots (QDs)
to construct sensors based on the structure-switching aptamer
design [141]. A thrombin aptamer was attached to QDs, and
a complementary DNA with a quencher was hybridized to
the aptamer, resulting in quenched QDs fluorescence.
Addition of thrombin released the quencher and an 14-fold
emission increase was observed.
Fluorescence anisotropy measurements have also been
used as transduction mechanism for aptamer sensors. These
assays can be performed with a single labeled aptamer
probe in homogeneous solutions without the need for target
separation or purification. Tan et al. labeled the 5′ end of
the PDGF aptamer with fluorescein [31] and increased
anisotropy on addition of PDGF was observed with a
detection limit of 0.22 nmol L
−1. Similarly, anisotropy-
based assays have been performed on the IgE aptamer
[142], the thrombin aptamer [143], and aptamers for
amyloid β-peptides [144].
Small molecule detection
Many aptamers designed for recognition of biologically
important small molecules have been modified into fluo-
rescence sensors [145]. Careful studies have been devoted
to the direct labeling of aptamers with fluorescence reporter
groups to optimize the performance and sensing ability of
such aptamers. Ellington and co-workers first explored
covalent labeling of fluorophores to aptamers by a rational
approach to sensor design [131]. On the basis of the
structure of the RNA aptamer for ATP, an acridine
fluorophore was attached at the site close to the binding
pocket but not directly involved in binding. This aptamer
3168 B. Juskowiakresulted in ATP-dependent fluorescence enhancement,
while labeling with fluorescein at the same position or at
the terminus of the aptamer failed to generate a signal
change. Interestingly, the same design strategy applied on
the ATP DNA aptamer and labeling with fluorescein
resulted in ATP-dependent signal changes, but the fluores-
cence increase was less than onefold. Yamana et al.
synthesized a bis-pyrene fluorophore and attached it to a
number of positions on the ATP DNA aptamer [146]. Only
labeling at particular positions resulted in ATP-dependent
fluorescence changes. They also attached a pyrene moiety
at the 2′-ribose positions on the ATP aptamer. Of the seven
positions tested, two gave an ATP-dependent fluorescence
increase [147]. Similar labeling has been reported by Weeks
and co-workers, who placed a Bodipy-FL fluorophore at
the 2′-ribose of the cytosine residues on three DNA
aptamers [148]. For the ATP aptamer and argininamide
aptamer, among the three cytosine residues tested, only
single positions generated fluorescence enhancement. In
contrast, all three positions tested on a tyrosinamide
aptamer resulted in an increase in fluorescence [148].
These studies demonstrated that it is possible to
rationally design aptamer sensors by strategically attaching
fluorophores to aptamers. This method often requires
knowledge of aptamer structures and a few trial-and-error
experiments. The fluorescence increase is relatively small
(<fourfold). Placing a fluorophore too close to the binding
site may disrupt binding, and fluorophores too far away
from the binding site may not result in fluorescence
changes.
Therefore, design of small-molecule probes based on
MB or other approaches similar to those used for detection
of nucleic acids and proteins were more widely used. For
example, MB design was reported by Morse for a
tobramycin sensor [149]. The RNA aptamer was modified
to adopt a hairpin structure and the two ends of the aptamer
were labeled with a fluorophore and a quencher to construct
sensors (Fig. 5a). However, in the two sequences tested, the
fluorescence increase in the presence of saturating tobra-
mycin concentration was only ∼10%, and a detection limit
of 30 μmol L
−1 was reported. Some aptamer beacons have
been designed on the basis of the fluorophore–quencher
approach but without the formation of an initial hairpin
structure. The cocaine RNA aptamer has been proposed as
a means of constructing such a sensor, because it has the
binding structure of a short hairpin flanked by two single-
stranded regions [150]. A fluorophore and a quencher were
labeled at the two ends, and high fluorescence intensity was
initially observed in the absence of cocaine (the aptamer
ends were separated in a single-stranded form). In the
presence of cocaine, the compact structure was formed and
the fluorophore was brought close to the quencher
(Fig. 5b). Fifty percent quenching was observed with
1 mmol L
−1 cocaine. Even in blood serum, 10 μmol L
−1
cocaine could be detected. Similar probes with a fluoro-
phore and a quencher on the two ends of an oligonucleotide
have been developed using the DNA aptamer for l-
argininamide [151] and adenosine aptamer [152]. A
detection limit of ∼5 μmol L
−1 was reported for the
adenosine probe with quenching efficiency up to 67%
[152]. An aptamer splitting approach has also been used by
Stojanowic et al. to construct cocaine and ATP sensors
[153]. Aptamers were split into two halves. One half was
labeled with a fluorophore and the other with a quencher. In
the absence of target molecule these two strands existed in
solution as monomers and a strong fluorescence signal was
observed. Target-dependent association of the two halves of
the aptamer brought the fluorophore and the quencher
together and quenching of fluorescence was observed
(Fig. 5e). These sensors were able to detect cocaine from
10 to 1250 μmol L
−1 and ATP from 8–2000 μmol L
−1.
Another design of ATP detection system was reported by Li
et al. who developed a general strategy for signaling
aptamer binding based on the structure-switching properties
of the aptamer [135, 154, 155]. Competitive binding of
target or complementary DNA constitutes a structure-
switching process between the two states. The DNA
competitor(s) hybridizes with the aptamer but enables
dehybridization when the aptamer binds to the target
molecule. Two DNA competitors labeled with a fluoro-
phore and a quencher were designed in such a way that they
were brought close to each other on hybridizing to the anti-
ATP aptamer, resulting in quenched fluorescence [135].
I nt h ep r e s e n c eo fA T P ,t h ea p t a m e rf r a g m e n ts w i t c h e dt o
the target-binding structure. As a result, the number of
base pairs between the quencher-labeled DNA and the
aptamer DNA was reduced, so that the quencher-labeled
DNA competitor dissociated in solution, giving an
increased fluorescence signal (Fig. 5c). Sensing of ATP
was demonstrated with a detection limits of 10 μmol L
−1
and a very high fluorescence increase (over 15-fold) [135].
Alternatively, a system with only one DNA competitor
was constructed (Fig. 5f), in which the aptamer carried a
fluorophore and a DNA strand was labeled with a
quencher [154] or the DNA strand was labeled with both
the fluorophore and the quencher and adopted an MB
structure after dehybridization [155]. In a recent design
reported by the Tan group, the aptamer and complemen-
tary DNA strand labeled with a fluorophore and a
quencher, respectively, were linked by a PEG chain to
form a hairpin structure of an MB type [156]. In the
presence of the ATP target, increased fluorescence was
observed.
Aptamers can be conjoined with nucleic acid enzymes
(ribozymes or deoxyribozymes) to generate a new class of
catalyst, so called aptazymes [3]. Aptazymes are nucleic
Nucleic acid-based fluorescent probes and their analytical 3169acid sequences that catalyze chemical reactions, for
example cleavage of nucleic acid targets, and can be
switched on (or shut off) by interaction of its recognition
part (aptamer) with an analyte. Fluorescent signal genera-
tion can be achieved by cleaving a FRET-labeled substrate
(Fig. 6a). Srinivasan et al. identified ADP-specific apta-
zymes that could be used as sensors of kinase activity
[157]. On activation by ADP, the hammerhead aptazyme
cleaved an oligonucleotide substrate, resulting in fluores-
cence signal generation. Achenbach and colleagues have
recently described design of an ATP-dependent aptazyme
by joining the 8-17 deoxyribozyme to the ATP-binding
DNA aptamer [158]. This aptazyme remained inactive in
the absence of the target, but when ATP was introduced, the
oligonucleotide was released and the activity of the
deoxyribozyme was restored (Fig. 6a). Nutiu and Li have
designed an assay that exploits a fluorescent DNA aptamer
to report the activity of alkaline phosphatase (ALP) [159].
The fluorescence of the aptamer was higher for adenosine
than for AMP.
Metal cation sensors
Some metal ions, for example lead and mercury, are harmful
environmental contaminants with a health risk to humans.
Sensors for easy detection of these metals are therefore highly
desirable. Advances in many different design principles for
aptazymes have led to development of DNAzyme-based
sensors for metal ions. These probes have been reported for
such metal ions as Cu
2+,Z n
2+,P b
2+, Hg
2+,U O 2
2+,a n dC a
2+
[160–171]. The first such probe was reported by Li and Lu
who designed a DNAzyme-based lead sensor (Fig. 6b)
[160]. The catalytic DNA used was 17E, a variant of the 8-
17 deoxyribozyme mentioned in the previous section. In the
absence of lead ions, the 17E had very weak activity towards
a fluorogenic RNA-containing substrate labeled with FRET
partners. When lead was present, however, 17E rapidly
cleaved the substrate, leading to a strong fluorescence signal
[160]. The signaling properties of this design have been
improved by adding another acceptor molecule to the other
end of the substrate [165]. The signaling of this new probe
was enhanced (five-times higher signal) because of back-
ground suppression [165]. A similar arrangement of FRET
labels was used for an uranium probe with 17-fold
fluorescence signal enhancement in the presence of uranium
ion [166]. Perrin and co-workers have engineered a mercury
sensor based on a deoxyribozyme whose activity could be
specifically inhibited by Hg(II) [162]. Li and co-workers
have reported several RNA-cleaving fluorescence-signaling
deoxyribozymes that were dependent on one or more
transition divalent metal ions, for example Mn(II), Cd(II),
and Ni(II) [163, 164]. Two strategies in the design of metal
ion-dependent DNAzymes can be distinguished. One utilizes
a molecular beacon consisting of two specific regions related
to a DNAzyme and a substrate. In the absence of target ion,
the MB has an intact structure with the fluorescence signal
quenched. When the target ion is bound, the fluorophore-
labeled substrate quenched by a quencher-modified DNA-
zyme is irreversibly cleaved and released to produce a
fluorescent signal [160–169]. Wang et al. [168]r e c e n t l y
proposed the DNAzyme for lead ion monitoring by applying
a unimolecular design with a leaving substrate DNA strand
labeled with a fluorophore l i n k e dt oah a i r p i n8 - 1 7
DNAzyme sequence labeled with a quencher. The hairpin
structure and the substrate were connected using poly T,
which brings the quencher into close proximity with the
fluorophore in the inactive state. In the presence of Pb
2+,
however, the leaving substrate fragment was cleaved by the
enzyme, releasing a fluorescent fragment. Liu and Lu
reported a highly sensitive and selective catalytic probe for
mercury that was based on a uranium-specific DNAzyme
containing thymine–thymine mismatches [169]. The Hg
2+
ions enhanced the DNAzyme activity through allosteric
interactions. In the absence of Hg
2+ ions, the DNAzyme was
incapable of binding UO2
2+ ions because the active
secondary structure could not form. Addition of Hg
2+ ions
stabilized the T–T mismatches and, restoring the stem-loop
structure, activated the DNAzyme to cleave the substrate,
releasing the fluorophore-labeled leaving strand and resulting
in increased fluorescence. The same strategy of Hg
2+ binding
between two thymine bases in DNA, which stabilizes the T–
T mismatch, has been used by Ono et al. in the fluorescent
sensor for Hg
2+ detection [170]. The two ends of a thymine-
rich DNA were labeled with a fluorophore and a quencher.
Addition of Hg
2+ led to the formation of a DNA hairpin that
caused fluorescence quenching. A detection limit of
40 nmol L
−1 was reported. Another probe design uses the
conformation alteration of the probe that results from
cleavage of the substrate by the DNAzyme. In this case,
the horseradish peroxidase (HRP)-mimicking DNAzyme is
Fig. 6 Schematic representation of generation of fluorescence with
aptazyme sensors for ATP (a) and Pb
2+ ion (b)
3170 B. Juskowiakactivated by a cleavage process, thus generating colorimetric
or chemiluminescence readout signals [171]. Yin et al.
reported such a dual-DNAzyme unimolecular probe with a
simple, label-free design [171]. The probe was a combina-
tion of a DNA substrate, a cleaving DNAzyme1 and an
HRP-mimicking DNAzyme2. In the absence of the target
metal ion, these three domains acted cooperatively in the
DNA-cleaving active state as a result of strong intramolec-
ular interactions, and the resulting structure revealed higher
stability than the G-quadruplex structure responsible for
activity of HRP-like DNAzyme2. When the target Cu(II) ion
was present, cleavage of a substrate by DNAzyme1
disturbed the intramolecular DNA conformation, and this
event resulted in an allosteric transformation from the active
state of DNAzyme1 to the active state of HRP-like
DNAzyme2 with a tetraplex structure, which in turn gave a
colorimetric signal [171].
The tetraplex structural motif found in HRP-like DNA-
zymes has been also used to develop fluorescence probes
for potassium ion or pH monitoring [29, 40, 172–176]. The
common idea behind these sensors was to exploit the metal
cation binding properties of quadruplex-forming DNA
sequences. After labeling with reporter fluorescent groups,
the oligonucleotides preserved their abilities to fold into a
quadruplex structure and to interact with metal cations with
binding affinity and selectivity comparable with that of
unmodified oligonucleotides [29, 40, 172, 173]. The
preferential ability of potassium to stabilize guanine
tetraplexes is commonly observed. Potassium has an ionic
radius of approximately 1.3 Å, and is believed to fit
exceptionally well in the cavities between guanine tetrads.
Three different transduction processes shown in Fig. 7 have
been proposed for construction of potassium fluorescent
probes with the use of quadruplex-forming oligonucleotides:
1. FRET between two fluorophores attached to the both
termini of the telomeric oligonucleotide (Fig. 7a)[ 29,
172, 173];
2. excimer emission of the pyrene-labeled thrombin
aptamer (Fig. 7b)[ 40, 174]; and
3. FRET between the cationic conjugated polymer and the
fluorescein-labeled quadruplex (Fig. 7c)[ 176].
In the first strategy, the G-rich oligonucleotides were
labeled with fluorophores suitable to serve as FRET
partners and the probes obtained were called PSO (potassium-
sensing oligonucleotide). Two FRET systems were reported,
P S O - 1a n dP S O - 2 ,w i t ht h et e l o m e r es e q u e n c ef r o mh u m a n
G3(TTAG3)3 and Oxytricha nova G4(T4G4)3, respectively, and
ac o m m o nF R E Tp a i r ,F A M - T A M R A[ 29, 172, 173]. The
selectivity ratio of PSO-1 for K
+ against Na
+ was 43,000; for
PSO-2 this value approaches 150 only [173]. Factors
responsible for the extremely high value of K/Na selectivity
of PSO-1 included inherent preferences of this quadruplex for
K
+ binding, a stabilizing effect of stacking interactions
between fluorophores (a chair-type or hybrid K
+ quadruplex
vs. a basket-type Na
+ form), and different FRET efficiency,
which is a function of interflurophore distance (quadruplex
structure). General observations regarding FRET in PSO-1
and PSO-2 systems with metal cations were:
1. FRET signal (sensitized fluorescence of TAMRA)
appeared only for K(I) and Na(I) complexes;
Fig. 7 Schematic illustration of strategies used to develop oligonu-
cleotide sensors for potassium ion: a FRET-based probe (a), an
excimer emission sensor based on pyrene-labeled thrombin binding
aptamer (b), and a FRET probe sensitive to the electrostatic
interactions between cationic conjugated polymer (CCP) and G-
quadruplex labeled with fluorescein (c)
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required to generate the FRET signal;
3. the intensity of sensitized fluorescence of TAMRA
finally attained was larger for Na
+ than that for K
+ ions;
and
4. multivalent metal cations (Mg
2+) caused quenching of
the donor fluorescence (FAM) only, without sensitiza-
tion of the TAMRA emission [172, 173].
Systematic studies have been carried out to assess the
effect of complexation of metal cation by PSO-1 on the
spectral properties of FRET donor (FAM) and acceptor
(TAMRA) [29]. Three different fluorescent DNA oligonu-
cleotides with human telomere sequence were investigated—
a dual-labeled PSO-1 probe and two reference telomeric 21-
mers,FAM-21and21-TAMRA,single-labeledatthe 5′ and3′
ends, respectively. Steady-state fluorescence, FRET, and
anisotropy measurements were carried out in the pres-
ence of selected cations (Et4N
+,L i
+,N a
+,K
+,M g
2+).
Fluorescence intensity of FAM-21 was sensitive to the
nature and concentration of cations. Anisotropy of FAM-
21 (but not 21-TAMRA) seemed to be sensitive to the G-
quadruplex formation, with a significant increase with
increasing cation concentration, and indicated some
restrictions in rotational depolarization of FAM. FRET
experiments revealed that although all tested cations
caused quenching of FAM fluorescence in PSO, only
Na
+ and K
+ ions induced sensitized emission of the
TAMRA acceptor. Fluorimetric detection of K
+ with PSO-
1 was possible at submicromolar concentrations under
optimum conditions, with a linear calibration graph in a
wide concentration range of K
+ (1–1000 μmol L
−1)[ 172].
An attempt has been made to construct potassium FRET
probes using the thrombin binding aptamer (TBA) sequence
and FAM or TAMRA fluorescence labels at either terminus,
with spacer DNA sequences of TmA( m= 2 ,4 ,o r6 )
introduced between FAM and the 5′ end [175]. The reference
probe (no spacer) did not result in sensitized emission of the
acceptor (TAMRA) in the presence of K
+, because of the
quenching of TAMRA fluorescence by dye–dye interactions
with FAM. When the spacer was introduced, the fluores-
cence of TAMRA was increased, because of prevention of
the dye–dye interaction. Both donor quenching and sensi-
tized emission of the acceptor could be used as sensitive
signals to monitor folding processes of quadruplex DNA.
These FRET results unambiguously confirmed that addition
of a spacer significantly reduced contact quenching and
improved the performance of FRET probes [175].
In contrast with the FRET approach, stacking interactions
between fluorophores are advantageous in the production of
efficient excimer emission when pyrene moieties serve as
fluorophores [37, 40, 174]. Therefore, another potassium
probe has been developed (denoted as PSO-py), which
exploited the pyrene excimer emission for transduction of
cation-binding (probe b in Fig. 7)[ 40, 174]. Two pyrene
moieties were attached to the thrombin biding aptamer
(TBA) termini. TBA is known to form a chair-type
quadruplex structure on binding to thrombin protein, and
this quadruplex incorporates K
+ with a 1:1 stoichiometry
[127]. Therefore, binding of potassium ion organized the 5′
and 3′ termini of TBA in such a way that two attached
pyrene molecules were arranged face-to-face (Fig. 7b).
Owing to this spatial orientation of pyrene rings, the PSO-
py/K
+ complex emitted excimer fluorescence whereas the
random coil structure of PSO-py in the absence of K
+ gave
only monomer emission. Consequently, the intensity of
excimer emission by PSO-py depended on the K
+ concen-
tration. The presence of other metal cations caused minor
interferences, because TBA forms weak complexes with
Na
+,M g
2+,a n dC a
2+ ions [127]. A modification of this assay
with improved signal-to-background ratio has been recently
proposed by Shi and co-workers [176]. A hairpin oligonu-
cleotide containing a sequence complementary to TBA, was
modified with pyrene moieties and hybridized with TBA
aptamer. The hybrid gave only monomer emission in the
absence of K
+, because the duplex rigid structure protected
the pyrene moieties from stacking interactions. In the
presence of K
+, the complementary Py-labeled oligonucleo-
tide was displaced from the aptamer, which adopted the
G-quadruplex structure. This structural transition was ac-
companied by excimer fluorescence of pyrene because the
self-hairpin structure of the complementary oligonucleotide
brought the pyrene moieties into close proximity. Under
optimum conditions, the relative fluorescence intensity of
pyrene was proportional to the concentration of K
+ in the
range 0.6–20 mmol L
−1.
Recently, we have reported lifetime measurements for G-
quadruplexes formed between metal cations (K
+,N a
+,S r
2+)
and pyrene-modified oligonucleotides with sequences of
thrombin binding aptamer (Py–TBA–Py) and human
telomeric sequence (Py–Htelom–Py) [48]. All decays of
investigated systems could be characterized by a tri-
exponential rate. Calculated lifetimes and their fractional
distributions depended on the sequence of attached oligo-
nucleotide and the nature of the metal cation that occupied
a tetraplex internal cavity. The monomer emission data
reflectedtheextentofquenchingofthepyreneexcitedstateon
interaction with nucleobases or with a second pyrene
molecule. The long-wavelength emission was ascribed to
pyrene excimer formation, which proved pyrene–pyrene
interactions. On the other hand, the structure of the quad-
ruplex seriously affected label–label and label–nucleobase
interactions. The quadruplex topology that enables efficient
label–label interactions, and thus generation of excimer
emission with very long lifetime, seemed to be a chair-type
structure formed by the Py–TBA–Py probe. Next, the hybrid
3172 B. Juskowiakand propeller-type structures of Py–Htelom–Py quadruplexes
facilitated deactivation of the excited state of pyrene, because
of stacking interactions between pyrene and guanine tetrads.
Finally, the Htelom quadruplex with the basket-type structure
and a diagonal TTA loop that disturbs both pyrene–pyrene
interactions and pyrene–guanine tetrad stacking resulted in
lengthening of the monomer pyrene lifetime.
He et al. [177] suggested use of another FRET sensor
based on quadruplex formation for potassium detection. As
oligonucleotide probe they used a TBA quadruplex labeled
at the 5′ terminus with fluorescein that served as FRET
acceptor. Unlike other oligonucleotide FRET-labeled sys-
tems [172], these authors used a cationic conjugated
polymer (CCP) as an external energy donor (Fig. 7c).
Amplification of the FRET signal of the acceptor (fluores-
cein) was expected as a result of excitation energy transfer
from a large number of fluorophore units in CPP (donor). In
the absence of K
+ (random coil conformation), the probe
resulted in inefficient FRET whereas formation of a G-
quadruplex on addition of KCl caused an increase in the
FRET signal (ca. 16-fold). Good performance of the system
was explained by the charge density around the DNA that
controlled the extent of association with CPP, and thus the
efficiency of FRET from the CCP to the fluorescein label.
This approach has the potential for high sensitivity,
because of the light-harvesting properties of the energy donor
(a conjugated polymer).
The tetraplex structure of DNA has also been reported to
be suitable for pH monitoring in the physiological range.
Cytosine-rich oligonucleotides associate under acidic con-
ditions to form a tetraplex i-motif consisting of two parallel-
stranded C–H–C
+ base-paired duplexes that are mutually
intercalated in an antiparallel orientation [178]. Krishnan
et al. [179] constructed a nanomachine called an “I-switch”
that consisted of three oligonucleotides O1, O2, and O3, in
which O1 and O2 were hybridized on to sites adjacent to
O3, leaving a one-base gap. The O1 and O2 probes had
single-stranded cytosine-rich overhangs designed such that
each overhang formed one-half of a bimolecular i-motif. At
acidic pH, these overhangs were protonated and the
assembly could fold to form an intramolecular i-motif.
The system adopted an extended conformation at pH 7.3,
whereas at pH 5 the single-stranded overhangs formed an i-
motif, yielding a “closed state” and I-switching action. The
I-switch, fluorescently labeled at its 3′ and 5′ termini with
Alexa-488 and Alexa-647 on O1 and O2, respectively, gave
a FRET signal at pH ∼5, with efficiency of 54–60%. No
significant FRET was observed in the open state at pH 7.3.
At pH 7.3 the donor lifetime of the probe was ∼3.5 ns,
whereas at pH ∼5 it was shortened to 2.1 ns. Moreover, the
I-switch could switch reversibly between the “closed” and
“open” states on variation of pH. To demonstrate its ability to
function inside living cells, the I-switch was used to map
spatial and temporal pH changes associated with the endo-
some maturation, by use of fluorescence microscopy [179].
Concluding remarks
This review mainly focuses on the molecular recognition
and sensing aspects of fluorescent oligonucleotide probes.
Nucleic acids are generally believed to be able to target any
analyte of choice. Enormous progress in the “omics” fields
and in chemical biology has been possible because of the
development of new rapid, accurate and cost-effective
methods for analysis of nucleic acids, proteins, and other
molecules, including metabolites. Various efficient and
practical signaling strategies have been successfully devel-
oped to transduce nucleic acid recognition into physically
detectable fluorescence signals. In addition, the rapid
development of oligonucleotide-based sensing is also a
result of superior properties of nucleic acids as excellent
sensors, including high stability, low cost, and ease of
synthesis or modification. Although many assays have been
successfully proved in real sample applications (especially
hybridization probes in FISH or QPCR), there is still a long
way to go from proving experimental feasibility to
demonstrating real-world applications of aptamer probes.
Most sensing work using oligonucleotide probes has been
performed on model systems, and few clinically relevant
targets have actually been tested. Most sensors have, in
addition. been developed and tested in buffer systems under
controlled laboratory settings. For real medical diagnosis
and environmental monitoring, significant matrix effects
must be carefully evaluated. he performance of reported
probes, especially in aptamer sensors, could decrease substan-
tially in serum or plasma samples. Therefore, it will take more
research and technological effort to optimize the sensors and
eliminate matrix effects for practically useful sensitivity and
specificity.Althoughpyreneprobesaregoodproofofconcept,
their excitation wavelength (<360 nm) might be a problem in
studies of biological samples. Other molecules with longer
fluorescence lifetimes may improve the time resolution
capabilities of the probes even further. One alternative is the
use of transition-metal complexes or lanthanide chelates,
which can have lifetimes of the order of milliseconds.
Another important issue is that current methods have
mostly been developed for in-vitro detection. To accomplish
in-vivo sensing, novel methods and materials are needed, for
example, nucleic acid–protein conjugates, new fluorophores,
for example QDs and other nanomaterials, or innovative
transduction techniques. With the advent of new time-
resolved fluorescence microscopes and with the recent
developments in fluorescence lifetime imaging microscopy
(FLIM),these kindsofprobeswillfindtheir place inthe study
of cell processes in vivo. Other transduction techniques, for
Nucleic acid-based fluorescent probes and their analytical 3173example two-photon excitation and multiple FRET labeling,
are also good prospects for detection purposes.
When a sufficient number of sensors has been obtained,
the next significant advance in this sensing field would be
the development of sensor arrays for more sophisticated
target analysis. The benefits of the sensor arrays come from
the possibility of simultaneous detection of multiple targets
(the capability of high-throughout analysis of complex
samples). The selectivity of a single sensor may, however,
be insufficient for reliable target identification. Similarly,
one target may induce different responses from sensors on
an array, thus forming a “fingerprints” signal.
In addition to detection of target analytes, oligonucleotide-
b a s e df l u o r e s c e n c es e n s o r sc a na l s ob eu s e da st o o l sf o rm a n y
research fields and practical applications, for example high
throughput drug screening, nanotechnology, and materials
science. Assuming an increasing demand for convenient and
effective sensors, one can expect continued and rapid develop-
ment and advances in nucleic acid- b a s e ds e n s i n gi nt h ef u t u r e .
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